All news

IXJ beats BBH on yield, volatility, and long-term returns

Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash

The article compares iShares Global Healthcare ETF (IXJ) and VanEck Biotech ETF (BBH) for 2026 healthcare investing. BBH offers higher short-term returns with a concentrated biotech focus. IXJ provides broader global diversification, lower volatility, better long-term performance, and a higher dividend yield. Cost, performance, risk, and portfolio contents are analyzed. IXJ is recommended over BBH.

Read original source

IXJ company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.